Lenacapavir Tablet clinical trials

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)

This study looks at a new drug, lenacapavir, given as an injection twice a year, and a daily tablet, F/TDF (Truvada), to prevent HIV. It compares how well they work, their safety, and how easy they are to use for people at higher risk of getting HIV.